Literature DB >> 30033911

Chronic Spontaneous Urticaria: The Devil's Itch.

Sarbjit S Saini1, Allen P Kaplan2.   

Abstract

Chronic urticaria is defined as the presence of urticaria for a period exceeding 6 weeks, assuming symptoms for most days of the week. It is divided into chronic inducible urticarias and chronic spontaneous urticaria, previously termed chronic idiopathic urticaria. The latter designation emphasizes that patients can experience urticaria independent of any exogenous stimulus even if one can define circumstances that may worsen symptoms. A search for such an external "cause" is fruitless because the underlying abnormality is "intrinsic," whether it is autoimmune, or some unknown process. Approximately 40% of patients with chronic spontaneous urticaria report accompanying episodes of angioedema, whereas 10% have angioedema as their primary manifestation. In most cases, it is a self-limiting disorder, persisting for 2 to 5 years in most cases, although 20% of patients suffer for more than 5 years. The treatment that has evolved is largely empiric, based on double-blind, placebo-controlled studies whenever possible, but is not yet targeted to any particular pathogenic mechanism. In this article, we review the current status regarding pathogenesis, discuss the diagnostic workup, and update the approach to treatment including consideration of published guidelines, our own experience, and guideline updates that are being prepared.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic urticaria; Pathogenesis; Treatment

Mesh:

Year:  2018        PMID: 30033911      PMCID: PMC6061968          DOI: 10.1016/j.jaip.2018.04.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  129 in total

1.  Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission.

Authors:  P Jacques; A Lavoie; P M Bédard; C Brunet; J Hébert
Journal:  J Allergy Clin Immunol       Date:  1992-06       Impact factor: 10.793

2.  Increased levels of serum IL-31 in chronic spontaneous urticaria.

Authors:  Ulrike Raap; Dorothea Wieczorek; Manuela Gehring; Inga Pauls; Sonja Ständer; Alexander Kapp; Bettina Wedi
Journal:  Exp Dermatol       Date:  2010-02-16       Impact factor: 3.960

Review 3.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

4.  How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria.

Authors:  Allen P Kaplan; Kusumam Joseph; Sarbjit S Saini
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Jul-Aug

5.  Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria.

Authors:  Ronit Confino-Cohen; Dorit Aharoni; Arnon Goldberg; Irena Gurevitch; Andreas Buchs; Mordechai Weiss; Joshua Weissgarten; Micha J Rapoport
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

6.  Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients.

Authors:  A Leznoff; G L Sussman
Journal:  J Allergy Clin Immunol       Date:  1989-07       Impact factor: 10.793

Review 7.  Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review.

Authors:  Pavel Kolkhir; Elena Borzova; Clive Grattan; Riccardo Asero; Dmitry Pogorelov; Marcus Maurer
Journal:  Autoimmun Rev       Date:  2017-10-14       Impact factor: 9.754

8.  Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients.

Authors:  Zahava Vadasz; Yuval Tal; Menachem Rotem; Vered Shichter-Confino; Keren Mahlab-Guri; Yael Graif; Aharon Kessel; Nancy Agmon-Levin; Ramit Maoz-Segal; Shmuel Kivity; Shira Benor; Idit Lachover-Roth; Yuri Zeldin; Migel Stein; Ori Toker; Gamal Hassoun; Shira Bezalel-Rosenberg; Elias Toubi; Ilan Asher; Zev Sthoeger
Journal:  J Allergy Clin Immunol Pract       Date:  2017-10-04

9.  Assessment of tissue fluid histamine levels in patients with urticaria.

Authors:  A P Kaplan; Z Horáková; S I Katz
Journal:  J Allergy Clin Immunol       Date:  1978-06       Impact factor: 10.793

10.  Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies.

Authors:  John A Eckman; Robert G Hamilton; Laura M Gober; Patricia M Sterba; Sarbjit S Saini
Journal:  J Invest Dermatol       Date:  2008-03-20       Impact factor: 8.551

View more
  10 in total

1.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.

Authors:  Benjamin Greiner; Savannah Nicks; Michael Adame; Jennifer McCracken
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-01       Impact factor: 10.817

3.  Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Authors:  Elizabeth García-Gómez; Edgardo Chapman; María Beatriz García-Paba; Jaime Ocampo-Gómez; Eduardo Egea-Bermejo; Gloria Garavito-De Egea; Luis Fang; Mauricio Sarrazola; Jorge Mario Sánchez-Caraballo; Carlos Serrano-Reyes; Diana Lucia Silva-Espinosa; Dolly Vanessa Rojas-Mejía; Sergio M Moreno
Journal:  Front Allergy       Date:  2022-05-20

4.  The Burden on Cohabitants of Patients with Chronic Spontaneous Urticaria: A Cross-Sectional Study.

Authors:  Manuel Sánchez-Díaz; Maria-Carmen Salazar-Nievas; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

Review 5.  Current and emerging treatments for chronic spontaneous urticaria.

Authors:  Kirti J Johal; Sarbjit S Saini
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-05       Impact factor: 6.347

Review 6.  Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.

Authors:  Ana M Giménez-Arnau; Andaç Salman
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

Review 7.  Emerging Therapies in Chronic Spontaneous Urticaria.

Authors:  Taek Ki Min; Sarbjit S Saini
Journal:  Allergy Asthma Immunol Res       Date:  2019-07       Impact factor: 5.764

Review 8.  Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.

Authors:  Gregorio Gomez
Journal:  Front Immunol       Date:  2019-02-07       Impact factor: 7.561

9.  Immunobiologicals in dermatology.

Authors:  Dimitri Luz Felipe da Silva; Elisa Nunes Secamilli; Mariana Valbon Beleli; Juliana Yumi Massuda; Andrea F E C Franca; Renata F Magalhães
Journal:  An Bras Dermatol       Date:  2022-03-18       Impact factor: 2.113

10.  Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Ken Washio; Takashi Omori; Yasumasa Kakei; Michihiro Hide; Chikako Nishigori
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.